Suppressed expression of miR-378 targeting gzmb in NK cells is required to control dengue virus infection

Cellular and Molecular Immunology

Volumn 13, Issue 5, 2016, Pages 700-708

  Liu, Shuyan ^a   Chen, Lingming ^a   Zeng, Ying ^b   Si, Lulu ^a   Guo, Xiaolan ^a   Zhou, Junmei ^a   Fang, Danyun ^a   Zeng, Gucheng ^a   Jiang, Lifang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

dengue virus; granzyme B; miRNA 378; NK cells

Indexed keywords

GRANZYME B; MICRORNA; MICRORNA 27A; MICRORNA 30E; MICRORNA 378; PERFORIN; UNCLASSIFIED DRUG; ANTAGOMIR; GRANZYME; MIRN378 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INDUCTION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; GZMB GENE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; MOUSE; NATURAL KILLER CELL; NONHUMAN; RNA BINDING; T LYMPHOCYTE ACTIVATION; TRANSLATION REGULATION; UPREGULATION; VIRUS REPLICATION; DRUG EFFECTS; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; VIROLOGY;

ANTAGOMIRS; BASE SEQUENCE; DENGUE; DENGUE VIRUS; DOWN-REGULATION; GRANZYMES; HUMANS; KILLER CELLS, NATURAL; MICRORNAS; PERFORIN; VIRUS REPLICATION;

EID: 84985898313     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2015.52     Document Type: Article

References (43)

1. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, et al. The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006; 368: 170-173
2. Halstead SB, Nimmannitya S, Cohen SN. Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J Biol Med 1970; 42: 311-328
3. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010; 8: S7-S16
4. Espina LM, Valero NJ, Hernandez JM, Mosquera JA. Increased apoptosis and expression of tumor necrosis factor-Alpha caused by infection of cultured human monocytes with dengue virus. Am J Trop Med Hyg 2003; 68: 48-53
5. Villar LA, Gelvez RM, Rodriguez JA, Salgado D, Parra B, Osorio L, et al. [Biomarkers for the prognosis of severe dengue]. Biomedica 2013; 33: 108-116
6. Prestwood TR, Morar MM, Zellweger RM, Miller R, May MM, Yauch LE, et al. Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-Alpha/beta receptor-deficient mice. J Virol 2012; 86: 12561-12570
7. Mathew A, Rothman AL. Understanding the contribution of cellular immunity to dengue disease pathogenesis. Immunol Rev 2008; 225: 300-313
8. Mongkolsapaya J, Duangchinda T, Dejnirattisai W, Vasanawathana S, Avirutnan P, Jairungsri A, et al. T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal? J Immunol 2006; 176: 3821-3829
9. Voskoboinik I, Smyth MJ, Trapani JA Perforin-mediated target-cell death and immune homeostasis.Nat Rev Immunol2006; 6: 940-952
10. van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R. Cytotoxic human CD4(1) T cells. Curr Opin Immunol 2008; 20: 339-343
11. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DI, Nogueira RM, Kubelka CF. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol 2006; 143: 345-356
12. Petitdemange C, Wauquier N, Rey J, Hervier B, Leroy E, Vieillard V. Control of acute dengue virus infection by natural killer cells. Front Immunol 2014; 5: 209
13. Weiskopf D, Angelo MA, de Azeredo EL, Sidney J, Greenbaum JA, Fernando AN, et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD81 T cells. Proc Natl Acad Sci U S A 2013; 110: E2046-E2053
14. Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, Peters B, et al. A protective role for dengue virus-specific CD81 T cells. J Immunol 2009; 182: 4865-4873
15. Torrentes-Carvalho A, Marinho CF, de Oliveira-Pinto LM, de Oliveira DB, Damasco PV, Cunha RV, et al. Regulation of T lymphocyte apoptotic markers is associated to cell activation during the acute phase of dengue. Immunobiology 2014; 219: 329-340
16. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-233
17. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355
18. Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, et al. miR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol 2012; 189: 5965-5975
19. Loveday EK, Diederich S, Pasick J, Jean F. Human microRNA-24 modulates highly pathogenic avian-origin H5N1 influenza A virus infection in A549 cells by targeting secretory pathway furin. J Gen Virol 2015; 96: 30-39
20. Mukherjee A, Di Bisceglie AM, Ray RB. Hepatitis C virus mediated enhancement of miR-373 impairs JAK/STAT signaling pathway. J Virol 2015; 89: 3356-3365
21. Zhu X, He Z, Hu Y, Wen W, Lin C, Yu J, et al. MicroRNA-30e suppresses dengue virus replication by promoting NF-kappaBdependent IFN production. PLoS Negl Trop Dis 2014; 8: e3088
22. Kim TD, Lee SU, Yun S, Sun HN, Lee SH, Kim JW, et al. Human microRNA-27a targets Prf1 and GzmB expression to regulate NKcell cytotoxicity. Blood 2011; 118: 5476-5486
23. Wang P, Gu Y, Zhang Q, Han Y, Hou J, Lin L, et al. Identification of resting and type I IFN-Activated human NK cell miRNomes reveals microRNA-378 and microRNA-30e as negative regulators of NK cell cytotoxicity. J Immunol 2012; 189: 211-221
24. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer Met al. Sensitive and viable identification of antigen-specific CD81T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65-78
25. Betts MR, Koup RA. Detection of T-cell degranulation: CD107a and b. Methods Cell Biol 2004; 75: 497-512
26. Chiang K, Sung TL, Rice AP. Regulation of cyclin T1 and HIV-1 Replication by microRNAs in resting CD41 T lymphocytes. J Virol 2012; 86: 3244-3252
27. Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol 2013; 14: 205-210
28. Heiss BL, Maximova OA, Thach DC, Speicher JM, Pletnev AG. MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype. J Virol 2012; 86: 5647-5659
29. Li Y, Masaki T, Lemon SM. miR-122 and the Hepatitis C RNA genome: more than just stability. RNA Biol 2013; 10: 919-923
30. Li Y, Masaki T, Yamane D, McGivern DR, Lemon SM. Competing and noncompeting activities of miR-122 and the 59 exonuclease Xrn1 in regulation of hepatitis C virus replication. Proc Natl Acad Sci U S A 2013; 110: 1881-1886
31. Terrier O, Textoris J, Carron C, Marcel V, Bourdon JC, Rosa-Calatrava M. Host microRNA molecular signatures associated with human H1N1 and H3N2 influenza A viruses reveal an unanticipated antiviral activity for miR-146a. J Gen Virol 2013; 94: 985-995
32. Smith JL, Grey FE, Uhrlaub JL, Nikolich-Zugich J, Hirsch AJ. Induction of the cellular microRNA, Hs-154, by West Nile virus contributes to virus-mediated apoptosis through repression of antiapoptotic factors. J Virol 2012; 86: 5278-5287
33. Wu S, He L, Li Y, Wang T, Feng L, Jiang L, et al. miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6. J Infect 2013; 67: 329-341
34. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-1581
35. Song L, Liu H, Gao S, Jiang W, Huang W. Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol 2010; 84: 8849-8860
36. Pan D, Mao C, Quattrochi B, Friedline RH, Zhu LJ, Jung DY, et al. MicroRNA-378 controls classical brown fat expansion to counteract obesity. Nat Commun 2014; 5: 4725
37. Pan B, Toms D, Shen W, Li J. MicroRNA-378 regulates oocyte maturation via the suppression of aromatase in porcine cumulus cells. Am J Physiol Endocrinol Metab 2015; 308: E525-E534
38. Yu BL, Peng XH, Zhao FP, Liu X, Lu J, Wang L, et al. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression. Int J Oncol 2014; 44: 1215-1222
39. Simmons CP, Popper S, Dolocek C, Chau TN, Griffiths M, Dung NT, et al. Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis 2007; 195: 1097-1107
40. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17: 189-220
41. Martinez J, Huang X, Yang Y. Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J Immunol 2008; 180: 1592-1597
42. Kohlmeier JE, Cookenham T, Roberts AD, Miller SC, Woodland DL. Type I interferons regulate cytolytic activity of memory CD8(1) T cells in the lung airways during respiratory virus challenge. Immunity 2010; 33: 96-105
43. Makedonas G, Hutnick N, Haney D, Amick AC, Gardner J, Cosma G, et al. Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells. PLoS Pathog 2010; 6: e1000798